✦ LIBER ✦

Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor

✍ Scribed by Kaoru Irisa; Katsuhiro Masago; Yosuke Togashi; Shiro Fujita; Yukimasa Hatachi; Akiko Fukuhara; Yuichi Sakamori; Yung Hak Kim; Tadashi Mio; Michiaki Mishima

Book ID: 107577377
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 294 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9764-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer

✍ Chia-Chi Lin; Chih-Hsin Yang 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Epidermal growth factor receptor express

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy

✍ Giuseppe Giaccone; Renee B. Iacona; Abderrahim Fandi; Mette Janas; Judith S. Och 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 494 KB

Trying to compose the puzzle with all th

Trying to compose the puzzle with all the pieces: Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

✍ Massimo Di Maio; Cesare Gridelli; Nicola Normanno; Francesco Perrone; Fortunato 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown promising activity in patients with non‐small cell lung cancer (NSCLC). Gefitinib has been the first of these drugs to be licensed for third‐line treatment of advanced NSCLC patients. Mor

Clinical significance of pretreatment se

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer

✍ Katsuhiro Masago; Shiro Fujita; Yukimasa Hatachi; Akiko Fukuhara; Keiichiro Saku 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Clinical impact of amphiregulin expressi

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

✍ Myung Hee Chang; Hee Kyung Ahn; Jeeyun Lee; Chan-Kwon Jung; Yoon-La Choi; Yeon H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB